Literature DB >> 18845616

Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury.

Xianwen Yi1, Kuikwon Kim, Weiping Yuan, Longquan Xu, Hyung-Suk Kim, Jonathon W Homeister, Nigel S Key, Nobuyo Maeda.   

Abstract

Alpha-lipoic acid (1, 2-dithiolane-3-pentanoic acid; LA), synthesized in mitochondria by LA synthase (Lias), is a potent antioxidant and a cofactor for metabolic enzyme complexes. In this study, we examined the effect of genetic reduction of LA synthesis on its antioxidant and anti-inflammatory properties using a model of LPS-induced inflammation in Lias+/- mice. The increase of plasma proinflammatory cytokine, TNF-alpha, and NF-kappaB at an early phase following LPS injection was greater in Lias+/- mice compared with Lias+/+ mice. The circulating blood white blood cell (WBC) and platelet counts dropped continuously during the initial 4 h. The counts subsequently recovered partially in Lias+/+ mice, but the recovery was impaired totally in Lias+/- mice. Administration of exogenous LA normalized the recovery of WBC counts in Lias+/- mice but not platelets. Enhanced neutrophil sequestration in the livers of Lias+/- mice was associated with increased hepatocyte injury and increased gene expression of growth-related oncogene, E-selectin, and VCAM-1 in the liver and/or lung. Lias gene expression in tissues was 50% of normal expression in Lias+/- mice and reduced further by LPS treatment. Decreased Lias expression was associated with diminished hepatic LA and tissue oxidative stress. Finally, Lias+/- mice displayed enhanced mortality when exposed to LPS-induced sepsis. These data demonstrate the importance of endogenously produced LA for preventing leukocyte accumulation and tissue injury that result from LPS-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845616      PMCID: PMC2626770          DOI: 10.1189/jlb.0308161

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  46 in total

Review 1.  Metabolic response to infection.

Authors:  W R Beisel
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

Review 2.  Regulation of the pathophysiology of tumor necrosis factor.

Authors:  L E DeForge; D T Nguyen; S L Kunkel; D G Remick
Journal:  J Lab Clin Med       Date:  1990-10

Review 3.  Immunomodulation by bacterial endotoxin.

Authors:  R Burrell
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

4.  Plasma lipid peroxides and antioxidants in human septic shock.

Authors:  A C Ogilvie; A B Groeneveld; J P Straub; L G Thijs
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines.

Authors:  R P Richardson; C D Rhyne; Y Fong; D G Hesse; K J Tracey; M A Marano; S F Lowry; A C Antonacci; S E Calvano
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

Review 6.  Assessing the antioxidative status in critically ill patients.

Authors:  Erich Roth; Nicole Manhart; Barbara Wessner
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2004-03       Impact factor: 4.294

7.  Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury.

Authors:  J A Hewett; P A Jean; S L Kunkel; R A Roth
Journal:  Am J Physiol       Date:  1993-12

8.  Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.

Authors:  N Marui; M K Offermann; R Swerlick; C Kunsch; C A Rosen; M Ahmad; R W Alexander; R M Medford
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 9.  Response of man to endotoxin.

Authors:  G D Martich; A J Boujoukos; A F Suffredini
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

10.  Lipid peroxidation in experimental septic rats.

Authors:  K Takeda; Y Shimada; T Okada; M Amano; T Sakai; I Yoshiya
Journal:  Crit Care Med       Date:  1986-08       Impact factor: 7.598

View more
  8 in total

1.  Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Kuikwon Kim; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2010-03-10       Impact factor: 5.162

2.  α-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice.

Authors:  Sylvia Hiller; Robert DeKroon; Longquan Xu; Jennifer Robinette; Witold Winnik; Oscar Alzate; Stephen Simington; Nobuyo Maeda; Xianwen Yi
Journal:  Free Radic Biol Med       Date:  2014-03-24       Impact factor: 7.376

3.  Reduced expression of lipoic acid synthase accelerates diabetic nephropathy.

Authors:  Xianwen Yi; Longquan Xu; Sylvia Hiller; Hyung-Suk Kim; Volker Nickeleit; Leighton R James; Nobuyo Maeda
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

4.  Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Authors:  Xianwen Yi; Longquan Xu; Sylvia Hiller; Hyung-Suk Kim; Nobuyo Maeda
Journal:  Atherosclerosis       Date:  2012-05-16       Impact factor: 5.162

5.  Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria.

Authors:  Pierre Eyenga; Damien Roussel; Jérôme Morel; Benjamin Rey; Caroline Romestaing; Loic Teulier; Shey-Shing Sheu; Joelle Goudable; Claude Négrier; Jean Paul Viale
Journal:  J Physiol Biochem       Date:  2014-02-26       Impact factor: 4.158

Review 6.  Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome.

Authors:  Xiangyi Cheng; Bing He
Journal:  Int J Womens Health       Date:  2022-04-01

7.  Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers.

Authors:  Yuan Cai; Qingchun He; Wei Liu; Qiuju Liang; Bi Peng; Jianbo Li; Wenqin Zhang; Fanhua Kang; Qianhui Hong; Yuanliang Yan; Jinwu Peng; Zhijie Xu; Ning Bai
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

Review 8.  Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.